Stevanato Group S.p.A. (STVN) is a publicly traded Healthcare sector company. As of September 8, 2026, STVN trades at $20.35 with a market cap of $5.60B and a P/E ratio of 0.00. STVN moved -0.93% today. Year to date, STVN is +0.99%; over the trailing twelve months it is -20.41%. Its 52-week range spans $12.89 to $28.00. Analyst consensus is strong buy with an average price target of $23.67. Rallies surfaces STVN's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies tracks the latest STVN news, catalysts, market updates, source links, and AI summaries when news is available.
| Metric | Value |
|---|---|
| Price | $20.35 |
| Market Cap | $5.60B |
| P/E Ratio | 0.00 |
| EPS | $0.00 |
| Dividend Yield | 0.05% |
| 52-Week High | $28.00 |
| 52-Week Low | $12.89 |
| Volume | 177.00K |
| Avg Volume | 0 |
| Revenue (TTM) | $0 |
| Net Income | $0 |
| Gross Margin | 0.00% |
5 analysts cover STVN: 0 strong buy, 4 buy, 1 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $23.67.